Shares in GSK lost 8% of their value today in the wake of the analyst comments, while Sanofi fell 3% and Haleon was down 6%, collectively wiping tens of billions of dollars off their valuations.

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

Haleon was a consumer health joint venture (JV), an over-the-counter (OTC) medicines business jointly created by Pfizer and GSK plc. GSK in 2019. GSK owned a controlling stake of 68% in the ...

Haleon was formed in 2022 from a combination of GSK and Pfizer’s consumer-health units. Pfizer has been cutting down its stake in Haleon, most recently raising £2.5 billion through a block ...

And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis ... in July 2022. GSK initially retained a 12.9% stake in Haleon after the flotation ...